China Pharma Holdings (CPHI) Raw Materials (2017 - 2024)
China Pharma Holdings' Raw Materials came in at $869,820 for Q3 2024, down 53.7% from $1.88 million a year earlier and down 27.2% from the prior quarter.
Powered by 
Analysis
China Pharma Holdings (CPHI) Raw Materials (2017 - 2024) Analysis & Trends
At the end of FY2023, China Pharma Holdings' Raw Materials was $1.85 million, up 0.5% from FY2022.
- Raw Materials carries a five-year compound annual growth rate of -10.1% (FY2018 to FY2023).
- Going back by year, Raw Materials was $1.84 million in FY2022 (unchanged), $1.84 million in FY2021 (-11.6%), $2.08 million in FY2020 (-1.5%) and $2.11 million in FY2019 (-32.9%).
- The Q3 2024 figure represents the lowest quarterly Raw Materials in data going back to Q4 2017.
- Year-over-year, Raw Materials has declined for three consecutive quarters, with an average decline of 13.1% over the last seven quarters.
- The fastest year-over-year change in Raw Materials over five years came in Q3 2023 (growth of 20.5%), and the weakest in Q3 2024 (a decline of 53.7%).
- Business Quant data shows CPHI's Raw Materials at $1.19 million (Q2 2024), $1.71 million (Q1 2024) and $1.85 million (Q4 2023) in the three quarters before Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | China Pharma Holdings | 22.89 Mn | 21.77 Mn | 83,566.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 869,820.00 |
| Jun 30, 2024 | 1.19 Mn |
| Mar 31, 2024 | 1.71 Mn |
| Dec 31, 2023 | 1.85 Mn |
| Sep 30, 2023 | 1.88 Mn |
| Jun 30, 2023 | 1.88 Mn |
| Mar 31, 2023 | 2.18 Mn |
| Dec 31, 2022 | 1.84 Mn |
| Sep 30, 2022 | 1.56 Mn |
| Jun 30, 2022 | 1.90 Mn |
| Dec 31, 2021 | 1.84 Mn |
| Sep 30, 2021 | 1.84 Mn |
| Jun 30, 2021 | 1.76 Mn |
| Mar 31, 2021 | 1.79 Mn |
| Dec 31, 2020 | 2.08 Mn |
| Sep 30, 2020 | 2.06 Mn |
| Jun 30, 2020 | 1.80 Mn |
| Mar 31, 2020 | 1.92 Mn |
| Dec 31, 2019 | 2.11 Mn |
| Sep 30, 2019 | 2.28 Mn |
API Access
China Pharma Holdings Raw Materials API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=raw-materials&ticker=CPHI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "raw-materials", "ticker": "CPHI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=raw-materials&ticker=CPHI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();